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The mechanisms of intracellular cholesterol transport are largely unknown. In this issue of Cell Metabolism,
Wang et al. (2010) identify amino acid residues on the lumenal lysosomal protein Niemann-Pick C2 (NPC2)
that are required for intralysosomal transfer of endocytosed cholesterol to membrane-bound NPC1 via
a process that avoids movement of hydrophobic cholesterol through the aqueous phase.The molecular mechanisms by which the
abundant mammalian membrane lipid,
cholesterol, is transported between and
assembled into intracellular membranes
remain largely undefined and represent
a frontier of cell biology. The fundamental
problem is that lipids, including choles-
terol, are poorly soluble in water and
therefore cannot diffuse freely within the
aqueous phase. Mechanisms proposed
for the intracellular movement of choles-
terol include vesicle transport, transfer
via soluble cytosolic transfer proteins,
and transport via transient membrane
contact through formation of interor-
ganelle protein complexes; the latter
mechanism is gaining favor for the inter-
membrane trafficking of some lipids
(reviewed in Voelker, 2008). The Brown
and Goldstein lab, among others, has
made enormous advances in under-
standing one aspect of this complex
problem: how cholesterol that is deliv-
ered to lysosomes via endocytosis of
low-density lipoproteins is released from
lysosomes in a process that requires
the two cholesterol-binding Niemann-
Pick C (NPC) proteins, NPC1 and NPC2.
In this issue, Wang et al. (2010) identify
a patch of amino acids on NPC2 that is
required for interaction between NPC1
and NPC2 and for the transfer of intraly-
sosomal cholesterol to the lysosomal
membrane.
Although the human gene encoding
NPC1 was identified in 1997 (Carstea
et al., 1997), clues to the biochemical
action of NPC1 are only now being
revealed. NPC1 is a lysosomal membrane
protein containing 13 putativemembrane-
spanning domains. Cholesterol binds to
the N-terminal domain (NTD) of NPC1,
which extends into the lysosomal lumen(Infante et al., 2008a). Unlike NPC1,
NPC2 is a soluble protein in the lysosomal
lumen (Naureckiene et al., 2000). Loss of
function of either NPC1 or NPC2 causes
the sequestration of unesterified choles-
terol in lysosomes of all cells and results
in the fatal disorder NPC disease. The
high-resolution structures of NPC2 (Fried-
land et al., 2003) and NPC1(NTD) (Kwon
et al., 2009) reveal that the 8-carbon side
chain of cholesterol is buried within the
hydrophobic binding pocket of NPC2
with the 3b-hydroxyl group exposed on
the surface. In contrast, NPC1 binds
cholesterol in the opposite orientation,
with the hydroxyl group inserted into the
binding site and the side chain partially
exposed. NPC2 binds cholesterol with
mM affinity and markedly accelerates
the bidirectional transfer of cholesterol
between lipid bilayers, particularly in an
acidic environment such as that in lyso-
somes (Cheruku et al., 2006). NPC2
mediates the transfer of cholesterol
between liposomes far more rapidly than
does NPC1. However, cholesterol move-
ment between NPC1 and liposomes
is enhanced >100-fold when NPC2 is
present (Infante et al., 2008b). Thus,
NPC2 and NPC1 are proposed to act in
tandem so that NPC2 delivers cholesterol
to/from NPC1. Alanine-scanning muta-
genesis identified a patch of 11 amino
acids that surround, but are not part of,
the cholesterol-binding site of NPC1
(NTD). These residues are essential for
cholesterol transfer from NPC2 (Kwon
et al., 2009) and for restoring the export
of cholesterol sequestered in lysosomes
of NPC1-deficient cells (Wang et al.,
2010).
Here, Wang et al. (2010) generated 57
mutant versions of NPC2 and identifiedCell Metabolism 1a patch of three residues adjacent to the
cholesterol-binding site of NPC2 that are
not required for cholesterol binding but
are essential for the transfer of cholesterol
from NPC2 to NPC1. Based on these
studies, a model was proposed in which
interaction between the identified patches
of amino acids on NPC2 and NPC1
displaces the helices surrounding the
entrance to the cholesterol-binding site
of NPC1(NTD), thereby facilitating choles-
terol transfer from NPC2 to NPC1. The
observations (Wang et al., 2010) support
amodel in which endocytosed cholesterol
is delivered from the lysosomal lumen to
the lysosomal limiting membrane without
movement of the hydrophobic cholesterol
through the aqueous phase (Figure 1). The
insertion of cholesterol into the lysosomal
membrane might involve the transmem-
brane domains of NPC1, including the
sterol-sensing motif that has been identi-
fied in other proteins involved in choles-
terol homeostasis.
The proposed model in which NPC2
and NPC1 directly interact raises the
question of whether or not the two
proteins become physically associated.
Wang and coworkers (Wang et al., 2010)
and others in the past were unable to
detect such a complex. Nevertheless,
the authors point out that substrate chan-
neling in a biochemical pathway probably
occurs via transient contact of the pro-
teins so that a stable protein complex
would not be observed. A similar type
of transient protein interaction might
occur during cholesterol transfer between
NPC2 and NPC1.
A remarkable advance in providing a
potential treatment for NPC disease and
in illuminating the function of the NPC
proteins is the finding that treatment2, August 4, 2010 ª2010 Elsevier Inc. 105
Figure 1. Proposed Mechanism of NPC1/NPC2-Mediated Export of
Cholesterol from Lysosomes
Cholesterol is delivered to lysosomes by receptor-mediated endocytosis of
low-density lipoproteins. The 8-carbon side chain of unesterified cholesterol
is inserted into the binding pocket of NPC2 (blue), a soluble protein in the lyso-
somal lumen. NPC2 hands over cholesterol to the N-terminal domain of the
transmembrane protein NPC1 (green) so that the cholesterol molecule is
inserted in the opposite orientation, with the hydroxyl group buried within the
binding pocket. Thus, the transfer of cholesterol to the membrane is accom-
plished without movement of this hydrophobic molecule across the aqueous
phase. The NPC1-bound cholesterol is exported from the lysosomal limiting
membrane to other organelles, such as the endoplasmic reticulum, by an
unknown mechanism (indicated by a question mark).
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Previewsof NPC-deficient mice with
the cholesterol-binding com-
pound b-cyclodextrin ap-
proximately doubles the life
span of the mice and attenu-
ates their neurodegeneration
(Liu et al., 2009). Cyclodextrin
appears to enter lysosomes
via bulk-phase endocytosis
(Rosenbaum et al., 2010)
and bypasses the require-
ment for NPC1 and NPC2 in
the export of cholesterol
from lysosomes. The obser-
vation that cyclodextrin at-
tenuates cholesterol synthe-
sis and enhances cholesterol
esterification implies that the
released cholesterol reaches
the endoplasmic reticulum.
The mechanism by which
cyclodextrin bypasses the
function of NPC1 and NPC2
is unknown, but further in-
vestigation of this intriguing
observation will likely shed
light on how these two pro-
teins participate in choles-
terol transport within lyso-
somes.
The findings of Wang et al.
provide a rational explanationfor how lipoprotein-derived cholesterol
that is delivered to lysosomes via endocy-
tosis is carried from the lysosomal interior
to the limiting membrane. Even if the
cholesterol were inserted into the inner
leaflet of the bilayer, it is not likely that
the transbilayer movement of cholesterol
would impede cholesterol exit from lyso-
somes, since movement of cholesterol106 Cell Metabolism 12, August 4, 2010 ª201across bilayers occurs very rapidly.
Future studies will hopefully elucidate
the mechanism by which cholesterol is
transferred from lysosomal membranes
to other organelles such as the endo-
plasmic reticulum, where cholesterol
homeostasis is regulated, and determine
the molecular components required for
this transfer.0 Elsevier Inc.REFERENCES
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